FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to compounds of formula (I) or their pharmaceutically acceptable acid addition salts, where R1 represents hydrogen atom or linear or branched (C1-C4)alkyl group; R2 represents linear or branched (C1-C4)alkyl group; R3 represents aryl or heteroaryl group; where aryl group represents naphthyl group, optionally substituted with one or several identical or different groups, selected from halogen atoms; linear or branched (C1-C6)alkyl group, which is non-substituted or is substituted with one or several halogen atoms; linear or branched (C1-C6)alkoxygroup; cyanogroup; or aminogroup, which is non-substituted or is substituted with one or two linear or branched (C1-C6)alkyl groups; and heteroaryl group represents bicyclic or tricyclic group, in which at least one of rings is aromatic, which contains from 1 to 3, identical or different, heteroatoms, selected from nitrogen, oxygen and sulphur, optionally substituted with one or several identical or different groups, selected from halogen atoms; linear or branched (C1-C6)alkyl group, which is non-substituted or is substituted with one or several halogen atoms; linear or branched (C1-C6)alkoxygroup; cyanogroup; or aminogroup, which is non-substituted or is substituted with one or two linear or branched (C1-C6)alkyl groups. Invention also relates to method of obtaining formula (I) compounds, pharmaceutical composition, containing formula (I) compound as active ingredient, and application of formula (I) compounds for preparation of medications.
EFFECT: formula (I) compounds, possessing selective activity with respect to α5 subunit of GABAA receptor.
16 cl, 5 dwg, 56 ex
Title | Year | Author | Number |
---|---|---|---|
3-SUBSTITUTED DERIVATIVES OF 3H-2,3-BENZODIAZEPINE, METHOD OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION | 1995 |
|
RU2146678C1 |
DERIVATIVES OF 2,3-BENZODIAZEPINE, INTERMEDIATE COMPOUNDS FOR THEIR SYNTHESIS AND AGENT ELICITING INHIBITORY ACTIVITY WITH RESPECT TO AMPA-RECEPTORS | 1997 |
|
RU2179557C2 |
BICYCLIC NITROIMIDAZOLES COVALENTLY CONNECTED TO REPLACED PHENYLOXAZOLYDINONES | 2009 |
|
RU2504547C2 |
NOVEL HETEROCYCLIC COMPOUND OR SALT THEREOF AND INTERMEDIATE COMPOUND THEREOF | 2007 |
|
RU2434868C2 |
HETEROARYL COMPOUNDS AS TKB INHIBITORS AND USE THEREOF | 2015 |
|
RU2742122C2 |
NOVEL HETEROCYCLIC COMPOUNDS AND USE THEREOF IN MEDICINE AND COSMETICS | 2015 |
|
RU2712971C2 |
SPIROOXYINDOLE DERIVATIVES AND APPLICATION THEREOF AS THERAPEUTIC AGENTS | 2006 |
|
RU2415143C2 |
SUBSTITUTED DIKETOPIPERAZINES AS OXYTOCIN ANTAGONISTS | 2002 |
|
RU2303032C2 |
IMIDAZOPYRIDIN-2-ONE DERIVATIVES, HAVING mTOR INHIBITING ACTIVITY | 2009 |
|
RU2478636C2 |
NOVEL COMPOUNDS OF CONDENSED HETEROCYCLYL-CARBOHYDRAZONOYL DICYANIDES AND USE THEREOF | 2021 |
|
RU2826002C1 |
Authors
Dates
2016-01-20—Published
2012-03-07—Filed